Market Research Logo

Fertility Market in the US 2016-2020

About Fertility

Couples with fertility issues are unable to conceive even after regular unprotected coitus (six months if the woman is over age 35). Female or male infertility factors account for one-third of the cases, where a couple is unable to conceive. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors.

In males, low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm can lead to infertility. In females, hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities can lead to infertility. Diagnosing the cause of infertility can be difficult but people with fertility issues have many treatment options depending on the underlying problem.

Technavio’s analysts forecast the fertility services market in the US to grow at a CAGR of 4.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the fertility treatment market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fertility drugs and the use of assisted reproductive technology (ART).

The market is divided into the following segments based on treatment type:

  • ART
  • Infertility drugs
Technavio's report, Fertility Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Cellcura
  • CooperSurgical
  • Intramed
  • Ferring Pharmaceuticals
  • Merck
Other
    prominent vendors
  • Abbott Laboratories
  • AbbVie
  • Actavis
  • Apricus Biosciences
  • AstraZeneca
  • Auxogyn
  • Bristol-Myers Squibb
  • Elelixis Diagnostics
  • Eli Lilly
  • EMD Serono
  • IKS International
  • In Vitro Care
  • Invo Bioscience
  • Irvine Scientific
  • IVFtech Aps
  • Life Global
  • Medical Electronic Systems
  • Meditex
  • Novartis
  • Ovascience
  • Pantec Biosolutions
  • Pfizer
  • Sanofi
  • Vivus
  • Xytex Cryo International
Market
    driver
  • Emergence of ART and acceptance of same-sex marriage
  • For a full, detailed list, view our report
Market
    challenge
  • High cost of fertility treatment
  • For a full, detailed list, view our report
Market
    trend
  • Increase in M&A
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Fertility Market in the US 2016-2020

Technavio recognizes the following companies as the key players in the Fertility Market in the US: Cellcura, CooperSurgical, Intramed, Ferring Pharmaceuticals and Merck

Other Prominent Vendors in the market are: Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Elelixis Diagnostics, Eli Lilly, EMD Serono, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Life Global, Medical Electronic Systems, Meditex, Novartis, Ovascience, Pantec Biosolutions, Pfizer, Sanofi, Vivus, and Xytex Cryo International.

Commenting on the report, an analyst from Technavio’s team said: “Vendors undergo M&A to expand their geographical presence, enhance their product portfolio, and attain profit margins. M&A allows vendors to gain proprietary technologies and innovative products of the acquired company. Small vendors undergo M&A to broaden their network and expand people's access to their new products.”

According to the report, the fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period.

Further, the report states that high cost of fertility treatment hinders the market growth.

Companies Mentioned

Cellcura, CooperSurgical, Intramed, Ferring Pharmaceuticals, Merck, Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Elelixis Diagnostics, Eli Lilly, EMD Serono, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Life Global, Medical Electronic Systems, Meditex, Novartis, Ovascience, Pantec Biosolutions, Pfizer, Sanofi, Vivus, Xytex Cryo International.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Number of ART procedures in US 2002-2013
      • Table Number of ART procedures in the US by fresh embryo from non-donor oocytes
      • Table Number of ART procedures in the US by thawed embryos from non-donor oocytes
  • Regulatory scenario in the US
  • Market landscape
    • Market overview
      • Table Fertility services market in US 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Infertility: An overview
    • Table Types of infertility
    • Etiology
      • Table Causes of male infertility
    • Etiology: Female infertility
      • Table Causes of female infertility
    • Signs and symptoms
    • Tests and diagnosis
    • Treatment
  • Stages of fertility treatment
    • Table Stages of fertility treatment
  • Cost analysis of ART
    • Direct cost
    • Indirect cost
  • Market segmentation by type
    • Table Segmentation of fertility services market in US by treatment type
    • Table Segmentation of fertility services market in US by treatment type 2015
    • Infertility drugs
    • Fertility drugs market in US
      • Table Fertility drugs market in US 2015-2020 ($ billions)
    • ART
      • Table Types of ART
      • Table IVF procedure
      • Table Success rate of IVF
      • Table Infertility rate in US by sex 2010
      • Table Infertility rate in US by age 2002 and 2010
      • Table Different categories of ART in US
      • Table Comparison of fresh and frozen ART cycle
    • ART market in US
      • Table ART market in US 2015-2020 ($ billions)
  • Market drivers
    • Emergence of ART and acceptance of same-sex marriage
      • Table ART procedures and number of infants born in US 2002-2011 (thousands)
      • Table Same-sex married couples in US 2008-2013 (thousands)
    • Increasing success rate of infertility treatment
    • Increase in infertility complications
      • Table Infertility by reproductive group in US
      • Table Adult Americans with obesity 2012
      • Table Adult Americans with obesity 2030
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of fertility treatment
      • Table Average cost of fertility services in US
    • Complications of fertility services
    • Limited reimbursement
      • Table States that require people to have insurance coverage for fertility services
    • Minimal regulations
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increase in M&A
      • Table Recent M&A
    • Rise in R&D
    • Establishment of new fertility clinics
      • Table Number of fertility clinics in US 2010-2014
  • Vendor landscape
    • Competitive scenario
    • Key news
    • Mergers and acquisitions
    • Licensing and collaborations
    • Market share analysis
      • Table CellCura: Key takeaways
      • Table CooperSurgical: Business segmentation by revenue 2014
      • Table IntegraMed: Key takeaways
      • Table Ferring Pharmaceuticals: Key takeaways
      • Table Merck: Business segmentation by revenue 2014
      • Table Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Merck: Geographical segmentation by revenue 2014
      • Table Merck: Key drivers in fertility services sector
      • Table Merck: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report